Patients with underlying cardiovascular disease were at an increased likelihood of developing abnormalities of liver function, certain laboratory tests, and more critical illness.
25 May 2020
This study found that patients with COVID-19 and pre-existing cardiovascular disease had higher white blood cell counts and markers of inflammation than those without cardiovascular disease. Additionally, COVID-19 patients with cardiovascular disease were at an increased likelihood of developing abnormalities of liver function, elevated creatinine levels (a marker of kidney dysfunction) and markers of tissue damage (i.e. lactate dehydrogenase), and more critical illness. Finally, the risk for death was also increased in patients with cardiovascular disease, especially those with multiple cardiovascular diseases. Cardiovascular disease was therefore found to be an independent risk factor for the development of more severe illness for those testing positive for the COVID-19 virus.
Summary by: Max Solish